DOYLE THOMAS JAMES 4
4 · Kura Oncology, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
DOYLE THOMAS JAMES
SVP, Finance & Accounting
Transactions
- Sale
Common Stock
2025-01-28$7.87/sh−699$5,502→ 89,315 total - Sale
Common Stock
2025-01-28$7.87/sh−1,122$8,832→ 88,193 total - Sale
Common Stock
2025-01-28$7.87/sh−2,241$17,641→ 90,901 total - Sale
Common Stock
2025-01-28$7.87/sh−887$6,982→ 90,014 total
Holdings
- 500(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
- [F2]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.
- [F3]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
- [F4]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.